27 April 2016 - Takeda today announced that the European Commission has granted an expanded indication for surgical patch TachoSil (human thrombin/human fibrogen) for use in adults for supportive sealing of the dura mater to prevent postoperative cerebrospinal leakage following neurological surgery. Dura mater is the outermost and most fibrous of the three membranes covering the brain and spinal cord.

TachoSil received Marketing Authorization in the European Union in June 2004. With the new expanded indication, TachoSil becomes the first and only dual action surgical patch approved in adults for:

• Improvement of hemostasis, or the arrest of bleeding
• Tissue sealing
• Suture support in vascular surgery
• Supportive sealing to prevent postoperative cerebrospinal leakage following neurological surgery

For more details, go to: http://www.takeda.com/news/2016/20160427_7391.html